COMPANY PROFILE

Company Profile

  • Company Name
    aiwell Inc.
  • Establishment
    January 23, 2018
  • Representative
    HIROYUKI MABUCHI
  • Location
    • Head Office
      • 〒102-0084
      9-3 Nibancho, Chiyoda-ku, Tokyo
    • Campus Innovation Center Tamachi
      • 〒108-0023
      3-3-6 Shibaura, Minato-ku, Tokyo
      Campus Innovation Center Tokyo INDEST

    • Branch

      • Sapporo
      〒060-0908
      4-1-20 Kitahachijo Higashi, Higashi-ku, Sapporo-shi, Hokkaido
      2nd Floor, Satudora Holdings
      EZOHUB SAPPORO
    • Proteomics Innovation Center（PIC）

      • PIC Kobe
      〒650-0047

      6-3-7 Minatojima Minamimachi, Chuo-ku, Kobe
      Creative Lab Kobe

      PIC Shin Kawasaki
      〒212-0032
      Room 221, KBIC Main Building, 7-7 Shin-Kawasaki, Saiwai-ku, Kawasaki City, Kanagawa
  • Capital
    450,133,500 yen (as of Dec 2023)
  • Main Shareholder
    Representative, Yokogawa Electric Corporation, Burroughs Inc, DIGIMERCE Inc, Taisho Pharmaceutical Co., Ltd., Future Food Fund Inc.,North Pacific Bank, Ltd., Contrail LLC, and individual investors
  • Business description
    • Realization of mass image data intercomparison by digital imaging and analysis of proteins from human, animals and other living organisms from trace amounts of samples in collaboration with Tokyo Institute of Technology.
    • Providing services to support drug discovery, diagnosis and remote medical care using AI before worsening of symptoms or onset of subjective symptoms under the mission 「Eliminating illnesses from the world and keep people healthy」
  • Suppliers
    Tokyo Institute of Technology, Sapporo Medical University, Consadole Co., Ltd., R-body project, Kirin Holdings Co., Ltd., Yokogawa Electric Corporation. Sumitomo Dainippon Pharma Co., Ltd. Taisho Pharmaceutical Co., Ltd.
View in Google Maps